Global Heart Healthy Ingredients Market By Type (Omega-3, Beta glucan, Phytosterol, Soy protein, and Others), By Application (Pharmaceuticals, Supplements, Beverages, Oils and fats, Bakery and confectionery, Dairy and frozen desserts, Sweet and savory snacks, and Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019-2028
- Published date: Jun 2022
- Report ID: 43411
- Number of Pages: 240
- Format:
- keyboard_arrow_up
- 1. Heart Healthy Ingredients Market Introduction
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 2. Executive Summary
- 2.1. Key Findings by Major Segments
- 2.2. Top strategies by Major Players
- 3. Global Heart Healthy Ingredients Market Overview
- 3.1. Heart Healthy Ingredients Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Opportunities
- 3.1.3. Restraints
- 3.1.4. Challenges
- 3.2. PESTLE Analysis
- 3.3. Opportunity Map Analysis
- 3.4. PORTER'S Five Forces Analysis
- 3.5. Market Competition Scenario Analysis
- 3.6. Product Life Cycle Analysis
- 3.7. Opportunity Orbits
- 3.8. Production Analysis by Region/Company
- 3.9. Industry chain Analysis
- 3.10. Marketing Strategy
- 3.1. Heart Healthy Ingredients Market Dynamics
- 4. Global Heart Healthy Ingredients Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
- 4.1. Global Heart Healthy Ingredients Market Analysis by Type: Introduction
- 4.2. Market Size and Forecast by Region
- 4.3. Omega-3
- 4.4. Beta glucan
- 4.5. Phytosterol
- 4.6. Soy protein
- 4.7. Others
- 5. Global Heart Healthy Ingredients Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
- 5.1. Global Heart Healthy Ingredients Market Analysis by Application: Introduction
- 5.2. Market Size and Forecast by Region
- 5.3. Pharmaceuticals
- 5.4. Supplements
- 5.5. Beverages
- 5.6. Oils and fats
- 5.7. Bakery and confectionery
- 5.8. Dairy and frozen desserts
- 5.9. Sweet and savory snacks
- 5.10. Others
- 6. Global Heart Healthy Ingredients Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
- 6.1. North America
- 6.1.1. North America Heart Healthy Ingredients Market: Regional Trend Analysis
- 6.1.1.1. US
- 6.1.1.2. Canada
- 6.1.1.3. Mexico
- 6.1.1. North America Heart Healthy Ingredients Market: Regional Trend Analysis
- 6.2.1. Europe
- 6.2.1. Europe Heart Healthy Ingredients Market: Regional Trend Analysis
- 6.2.1.1. Germany
- 6.2.1.2. France
- 6.2.1.3. UK
- 6.2.1.4. Russia
- 6.2.1.5. Italy
- 6.2.1.6. Spain
- 6.2.1.7. Rest of Europe
- 6.2.1. Europe Heart Healthy Ingredients Market: Regional Trend Analysis
- 6.3. Asia-Pacific
- 6.3.1. Asia-Pacific Heart Healthy Ingredients Market: Regional Trend Analysis
- 6.3.1.1. China
- 6.3.1.2. Japan
- 6.3.1.3. Korea
- 6.3.1.4. India
- 6.3.1.5. Rest of Asia-Pacific
- 6.3.1. Asia-Pacific Heart Healthy Ingredients Market: Regional Trend Analysis
- 6.4. Latin America
- 6.4.1. Latin America Heart Healthy Ingredients Market: Regional Trend Analysis
- 6.4.1.1. Brazil
- 6.4.1.2. Argentina
- 6.4.1.3. Rest of Latin America
- 6.4.1. Latin America Heart Healthy Ingredients Market: Regional Trend Analysis
- 6.5. Middle East and Africa
- 6.5.1. Middle East and Africa Heart Healthy Ingredients Market: Regional Trend Analysis
- 6.5.1.1. GCC
- 6.5.1.2. South Africa
- 6.5.1.3. Israel
- 6.5.1.4. Rest of MEA
- 6.5.1. Middle East and Africa Heart Healthy Ingredients Market: Regional Trend Analysis
- 6.1. North America
- 7. Global Heart Healthy Ingredients Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 7.1. Market Share Analysis
- 7.2. Company Profiles
- 7.3. Aker Biomarine AS (Norway)
- 7.3.1. Company Overview
- 7.3.2. Financial Highlights
- 7.3.3. Product Portfolio
- 7.3.4. SWOT Analysis
- 7.3.5. Key Strategies and Developments
- 7.4. Andean Grain Products Ltd. (UK)
- 7.4.1. Company Overview
- 7.4.2. Financial Highlights
- 7.4.3. Product Portfolio
- 7.4.4. SWOT Analysis
- 7.4.5. Key Strategies and Developments
- 7.5. BASF SE (Germany)
- 7.5.1. Company Overview
- 7.5.2. Financial Highlights
- 7.5.3. Product Portfolio
- 7.5.4. SWOT Analysis
- 7.5.5. Key Strategies and Developments
- 7.6. Bioriginal Food & Science Corporation (Canada)
- 7.6.1. Company Overview
- 7.6.2. Financial Highlights
- 7.6.3. Product Portfolio
- 7.6.4. SWOT Analysis
- 7.6.5. Key Strategies and Developments
- 7.7. BTSA Biotecnologias Aplicadas SL (Spain)
- 7.7.1. Company Overview
- 7.7.2. Financial Highlights
- 7.7.3. Product Portfolio
- 7.7.4. SWOT Analysis
- 7.7.5. Key Strategies and Developments
- 7.8. Ceapro Inc. (Canada)
- 7.8.1. Company Overview
- 7.8.2. Financial Highlights
- 7.8.3. Product Portfolio
- 7.8.4. SWOT Analysis
- 7.8.5. Key Strategies and Developments
- 7.9. Croda International Plc. (UK)
- 7.9.1. Company Overview
- 7.9.2. Financial Highlights
- 7.9.3. Product Portfolio
- 7.9.4. SWOT Analysis
- 7.9.5. Key Strategies and Developments
- 7.10. Devansoy Inc. (USA)
- 7.10.1. Company Overview
- 7.10.2. Financial Highlights
- 7.10.3. Product Portfolio
- 7.10.4. SWOT Analysis
- 7.10.5. Key Strategies and Developments
- 7.11. Deyang Huatai Biopharm Resource Co., Ltd (China)
- 7.11.1. Company Overview
- 7.11.2. Financial Highlights
- 7.11.3. Product Portfolio
- 7.11.4. SWOT Analysis
- 7.11.5. Key Strategies and Developments
- 7.12. E. I. du Pont de Nemours (USA)
- 7.12.1. Company Overview
- 7.12.2. Financial Highlights
- 7.12.3. Product Portfolio
- 7.12.4. SWOT Analysis
- 7.12.5. Key Strategies and Developments
- 7.13. Eden Foods, Inc. (USA)
- 7.13.1. Company Overview
- 7.13.2. Financial Highlights
- 7.13.3. Product Portfolio
- 7.13.4. SWOT Analysis
- 7.13.5. Key Strategies and Developments
- 7.14. FMC Corporation (USA)
- 7.14.1. Company Overview
- 7.14.2. Financial Highlights
- 7.14.3. Product Portfolio
- 7.14.4. SWOT Analysis
- 7.14.5. Key Strategies and Developments
- 7.15. Frutarom Industries Ltd (Israel)
- 7.15.1. Company Overview
- 7.15.2. Financial Highlights
- 7.15.3. Product Portfolio
- 7.15.4. SWOT Analysis
- 7.15.5. Key Strategies and Developments
- 7.16. Golden Omega SA (Chile)
- 7.16.1. Company Overview
- 7.16.2. Financial Highlights
- 7.16.3. Product Portfolio
- 7.16.4. SWOT Analysis
- 7.16.5. Key Strategies and Developments
- 7.17. Harvest Innovations LLC (USA)
- 7.17.1. Company Overview
- 7.17.2. Financial Highlights
- 7.17.3. Product Portfolio
- 7.17.4. SWOT Analysis
- 7.17.5. Key Strategies and Developments
- 7.18. Koninklijke DSM N.V. (Netherlands)
- 7.18.1. Company Overview
- 7.18.2. Financial Highlights
- 7.18.3. Product Portfolio
- 7.18.4. SWOT Analysis
- 7.18.5. Key Strategies and Developments
- 7.19. Lipofoods SLU (Spain)
- 7.19.1. Company Overview
- 7.19.2. Financial Highlights
- 7.19.3. Product Portfolio
- 7.19.4. SWOT Analysis
- 7.19.5. Key Strategies and Developments
- 7.20. Marine ingredients LLC (USA)
- 7.20.1. Company Overview
- 7.20.2. Financial Highlights
- 7.20.3. Product Portfolio
- 7.20.4. SWOT Analysis
- 7.20.5. Key Strategies and Developments
- 7.21. Natural Products, Inc. (USA)
- 7.21.1. Company Overview
- 7.21.2. Financial Highlights
- 7.21.3. Product Portfolio
- 7.21.4. SWOT Analysis
- 7.21.5. Key Strategies and Developments
- 7.22. Nexira SAS (France)
- 7.22.1. Company Overview
- 7.22.2. Financial Highlights
- 7.22.3. Product Portfolio
- 7.22.4. SWOT Analysis
- 7.22.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- 1. Heart Healthy Ingredients Market Introduction
- Aker Biomarine AS (Norway)
- Andean Grain Products Ltd. (UK)
- BASF SE (Germany)
- Bioriginal Food & Science Corporation (Canada)
- BTSA Biotecnologias Aplicadas SL (Spain)
- Ceapro Inc. (Canada)
- Croda International Plc. (UK)
- Devansoy Inc. (USA)
- Deyang Huatai Biopharm Resource Co., Ltd (China)
- E. I. du Pont de Nemours (USA)
- Eden Foods, Inc. (USA)
- FMC Corporation (USA)
- Frutarom Industries Ltd (Israel)
- Golden Omega SA (Chile)
- Harvest Innovations LLC (USA)
- Koninklijke DSM N.V. (Netherlands)
- Lipofoods SLU (Spain)
- Marine ingredients LLC (USA)
- Natural Products, Inc. (USA)
- Nexira SAS (France)
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |